
Judd Legum @JuddLegum
3. In 2018, Bright's boss diverted money from his budget to spend $40 million on an inferior antiviral drug. Experts across government advised against buying the drug. The company was represented by a politically-connected consultant. https://t.co/mZ9GlyXOeU — PolitiTweet.org